← Back to Clinical Trials
Recruiting NCT07681661

NCT07681661 Massage Gun vs Deep Friction Massage for Upper Trapezius Trigger Points

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07681661
Status Recruiting
Phase
Sponsor Ibadat International University, Islamabad
Condition Myofacial Trigger Points of Upper Trapezius
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-01-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 24 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Massage Gun TherapyDeep Friction Massage Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-01-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares the effectiveness of Massage Gun Therapy and Deep Friction Massage in individuals with upper trapezius myofascial trigger points. The interventions will be evaluated for their effects on pain intensity, pressure pain threshold, cervical range of motion, and neck disability. The aim is to determine which treatment is more effective in reducing pain and improving functional outcomes.

Eligibility Criteria

Inclusion Criteria: Presence of active trigger points in the upper trapezius (confirmed by palpation, referred pain pattern, and pain reproduction)(travell and simson's method). Moderate to severe pain (VAS\>4/10). No prior treatment for neck/shoulder pain in past 4 weeks. Age 24-45 years (young adults according to WHO classification) Both genders Exclusion Criteria:History of cervical spine surgery or severe musculoskeletal pathology. Neurological deficits. Systemic disease (e.g., rheumatoid arthritis, fibromyalgia). Recent trauma or fractures in the neck/shoulder region. Current pregnancy. \-

Contact & Investigator

Central Contact

MUHAMMAD ASHAR RAFI, DPT, MS-NMPT

✉ ashar.rafi@uipt.iiui.edu.pk

📞 0092-308-3407837

Principal Investigator

MUHAMMAD ASHAR RAFI, DPT, MS-NMPT

PRINCIPAL INVESTIGATOR

Ibadat International University, Islamabad

Frequently Asked Questions

Who can join the NCT07681661 clinical trial?

This trial is open to participants of all sexes, aged 24 Years or older, up to 45 Years, studying Myofacial Trigger Points of Upper Trapezius. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07681661 currently recruiting?

Yes, NCT07681661 is actively recruiting participants. Contact the research team at ashar.rafi@uipt.iiui.edu.pk for enrollment information.

Where is the NCT07681661 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07681661 clinical trial?

NCT07681661 is sponsored by Ibadat International University, Islamabad. The principal investigator is MUHAMMAD ASHAR RAFI, DPT, MS-NMPT at Ibadat International University, Islamabad. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology